4647 clinical trials
359 cell line models
48 approved drugs
Molecular Synopsis
Drugs and clinical candidates

48 drugs have received FDA approval for Lymphoma:

  • Acalabrutinib
  • Axicabtagene Ciloleucel
  • Belinostat
  • Bendamustine Hydrochloride
  • Bexarotene

534 drugs have a clinical trial registered for Lymphoma.

3428 compounds have been tested in Lymphoma (2320 <= 500nM potency).

Sources:,, ChEMBL.

Clinical trials
There are 4647 clinical trials for Lymphoma, 3208 of which have one or more drug interventions, 1439 with no drug intervention.
Cell line models

There are 359 Cell Line Models for Lymphoma.

Source: COSMIC
Cell line models

Please note the mappings below are based on an imperfect algorithm. If you notice any anomalies please report them to us.

The following terms have been mapped from mesh condition terms to Lymphoma:
  • Lymphoma, Non-Hodgkin
  • Lymphoma, Extranodal NK-T-Cell
  • Lymphatic Metastasis
  • Lymphoma
  • Plasmablastic Lymphoma
The following terms have been mapped from to Lymphoma:
  • T-cell lymphoblastic lymphoma
  • Lymphomatous meningitis (lymphoma that has spread to the meninges). It is given as intrathecal therapy
  • Peripheral T-cell lymphoma that has the CD30 protein. It is given with cyclophosphamide, doxorubicin hydrochloride, and prednisone
  • Peripheral T-cell lymphoma in patients whose disease has not gotten better with other chemotherapy or has recurred (come back)
  • Follicular lymphoma that has relapsed. It is used in adults who have received at least two other systemic treatments